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The scaffold protein spinophilin is a regulatory subunit of 
phosphatase 1a (PP1a) located at 17q21.33. This region is 
frequently associated with microsatellite instability and 
LOH and contains a relatively high density of known tumor 
suppressor genes (such as BRCA1), putative tumor 
suppressor genes, and several unidentified candidate tumor 
suppressor genes located distal to BRCA1. We have also 
recently found that Spn protein is lost in 20% and reduced 
in another 37% of human lung tumors. Furthermore, in 
animal models, loss of SPN increases tumorigenesis in 
vivo. We found that loss of Spn increases the onset of 
lymphoma in mice, and increases the aparition of mammary 
carcinomas in a mutant p53 background. To determine how 
loss of Spinophilin may contribute to tumorigenesis we 
explored the contribution of SPN to PP1a-mediated Rb 
regulation and their relationship to tumorigenesis. We found 
that the loss of Spinophilin downregulated PPP1CA and 
PP1a activity, resulting in a high level of pRb, which in 
turn, resulted in increased p53 activity through ARF. 
However, in the absence of p53, reduced levels of SPN 
enhanced the tumorigenic potential of the cells. 
Furthermore, the ectopic expression of SPN in human 
tumor cells from different types of malignancies greatly 
reduced cell growth. Taken together, our results show that 
the loss of Spinophilin induces a proliferative response by 
increasing Rb phosphorylation, which in turn activates 
p53, thereby, at least partially, neutralizing the 
proliferative response. The absence of p53 bypasses this 
barrier and enhances the malignant phenotype. Therefore, 
we suggest that Spinophilin may be the tumor suppressor 
gene that is located at 17q21.33, distal to BRCA1, and 
that its tumor suppressive function is dependent on the 
absence of p53. 
